These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10447724)

  • 1. Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes.
    Lucas AD; Halliday GM
    Immunology; 1999 May; 97(1):130-7. PubMed ID: 10447724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin.
    Halliday GM; Le S
    Int Immunol; 2001 Sep; 13(9):1147-54. PubMed ID: 11526095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Langerhans' cell density by a skin tumour-derived cytokine.
    Halliday GM; Lucas AD; Barnetson RS
    Immunology; 1992 Sep; 77(1):13-8. PubMed ID: 1398759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive tumour necrosis factor alpha but not granulocyte-macrophage colony-stimulating factor correlates inversely with Langerhans's cell numbers in skin tumours.
    Rubel DM; Barnetson RS; Halliday GM
    Int J Cancer; 1998 Jan; 75(2):210-6. PubMed ID: 9462710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.
    Halliday GM; Lucas AD
    Immunology; 1993 Aug; 79(4):621-6. PubMed ID: 8406587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunology; 2002 Apr; 105(4):466-77. PubMed ID: 11985667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Ia+ Langerhans cell numbers in vivo by cultured epidermis derived supernatants and by GM-CSF.
    O'Sullivan GM; Sluyter R; Boswell CM; Barnetson RS; Halliday GM
    Exp Dermatol; 1996 Feb; 5(1):28-37. PubMed ID: 8624609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system.
    Weber F; Byrne SN; Le S; Brown DA; Breit SN; Scolyer RA; Halliday GM
    Cancer Immunol Immunother; 2005 Sep; 54(9):898-906. PubMed ID: 15776284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.
    Cumberbatch M; Kimber I
    Immunology; 1992 Feb; 75(2):257-63. PubMed ID: 1551688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration.
    Cumberbatch M; Dearman RJ; Kimber I
    Immunology; 1997 Nov; 92(3):388-95. PubMed ID: 9486113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells.
    Wang B; Kondo S; Shivji GM; Fujisawa H; Mak TW; Sauder DN
    Immunology; 1996 Jun; 88(2):284-8. PubMed ID: 8690462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism.
    Cumberbatch M; Dearman RJ; Antonopoulos C; Groves RW; Kimber I
    Immunology; 2001 Mar; 102(3):323-30. PubMed ID: 11298831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
    Price AA; Cumberbatch M; Kimber I; Ager A
    J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha.
    Cumberbatch M; Fielding I; Kimber I
    Immunology; 1994 Mar; 81(3):395-401. PubMed ID: 7911448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans cell migration into ultraviolet light-induced squamous skin tumors is unrelated to anti-tumor immunity.
    Halliday GM; Reeve VE; Barnetson RS
    J Invest Dermatol; 1991 Nov; 97(5):830-4. PubMed ID: 1680931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytosis by dendritic cells rather than MHC IIhigh macrophages is associated with skin tumour regression.
    Byrne SN; Halliday GM
    Int J Cancer; 2003 Sep; 106(5):736-44. PubMed ID: 12866034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.
    Jolles S; Christensen J; Holman M; Klaus GB; Ager A
    Clin Exp Immunol; 2002 Sep; 129(3):519-26. PubMed ID: 12197894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress.
    Byrne SN; Halliday GM
    Cancer Immunol Immunother; 2003 Jun; 52(6):396-402. PubMed ID: 12739069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes.
    Ma J; Wang JH; Guo YJ; Sy MS; Bigby M
    Cell Immunol; 1994 Oct; 158(2):389-99. PubMed ID: 7923390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.